The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis
Authors:
Open Access
- 1 January 2024
- journal article
- review article
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 29
Abstract
Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumulation of monocytes and lymphocytes on the vessel wall. This suggests that inflammation may play a crucial role in the occurrence and progression of atherosclerosis. As research deepens, other pathological factors have also been found to influence the development of the disease. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a recently discovered target of inflammation that has gained attention in recent years. Numerous studies have provided evidence for the causal role of this pathway in atherosclerosis, and its downstream signaling factors play a significant role in this process. This brief review aims to explore the crucial role of the JAK/STAT pathway and its representative downstream signaling factors in the development of atherosclerosis. It provides a new theoretical basis for clinically affecting the development of atherosclerosis by interfering with the JAK/STAT signaling pathway.Keywords
This publication has 83 references indexed in Scilit:
- Autophagy, Hyperlipidemia, and Atherosclerosis2020
- Atherosclerosis: orchestrating cells and biomolecules involved in its activation and inhibition2020
- JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future ProspectsDrugs, 2017
- Retinoic acid amide inhibits JAK/STAT pathway in lung cancer which leads to apoptosisTumor Biology, 2015
- The Specific Roles of JAK/STAT Signaling Pathway in SepsisInflammation, 2015
- Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase α1 via a mitogen-activated protein kinase and c-Jun pathwayArchives of Biochemistry and Biophysics, 2012
- Suppression of atherogenesis by delivery ofusing adeno-associated virus type 2 in LDLR knockout miceBiochemical and Biophysical Research Communications, 2006
- TNF? and the TNF receptor superfamily: Structure-function relationship(s)Microscopy Research and Technique, 2000
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Cell division versus cell death: A functional model of multistep neoplasiaMolecular Carcinogenesis, 1993